Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.15M | 9.13M | 9.12M | 8.87M | 8.90M |
| Depreciation & Amortization | 46.00K | 67.00K | 90.00K | 112.00K | 122.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.87M | 27.03M | 25.10M | 24.21M | 25.44M |
| Operating Income | -28.87M | -27.03M | -25.10M | -24.21M | -25.44M |
| Income Before Tax | -30.33M | -40.50M | -33.56M | -55.70M | -37.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.33 | -40.50 | -33.56 | -55.70 | -37.32 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.33M | -40.50M | -33.56M | -55.70M | -37.32M |
| EBIT | -28.87M | -27.03M | -25.10M | -24.21M | -25.44M |
| EBITDA | -28.83M | -26.97M | -25.01M | -24.10M | -25.32M |
| EPS Basic | -15.07 | -42.34 | -54.59 | -94.16 | -124.41 |
| Normalized Basic EPS | -9.08 | -26.17 | -34.09 | -58.85 | -77.76 |
| EPS Diluted | -15.07 | -42.34 | -54.59 | -94.16 | -124.41 |
| Normalized Diluted EPS | -9.08 | -26.17 | -34.09 | -58.85 | -77.76 |
| Average Basic Shares Outstanding | 13.54M | 8.48M | 4.73M | 2.69M | 1.35M |
| Average Diluted Shares Outstanding | 13.54M | 8.48M | 4.73M | 2.69M | 1.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |